November 18, 2017  Last Update: December 21, 2016, 11:10 pm

Glaxo SmithKline Guilty: $3 Billion Fine for Wellbutrin, Others

Updated: GlaxoSmithKline has admitted guilt in a landmark case involving misleading marketing claims, bribes, improper rebating, and failure to report safety issues. They’ve been fined $3 Billion. The details are amazing.